Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 10
Original Research
Progression-free survival/time to progression as a potential surrogate for overall survival in HR+, HER2– metastatic breast cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 17,774 | Dovepress* | 8,655+ | 1,306 | 9,961 | |
| PubMed Central* | 9,119 | 669 | 9,788 | ||
| Totals | 17,774 | 1,975 | 19,749 | ||
| *Since 4 May 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar